Bionano Genomics
BNGO
32 hedge funds and large institutions have $1.02M invested in Bionano Genomics in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 8 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
0% more funds holding
Funds holding: 32 → 32 (0)
0.85% less ownership
Funds ownership: 8.7% → 7.85% (-0.85%)
25% less capital invested
Capital invested by funds: $1.35M → $1.02M (-$336K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$129K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$35.9K |
| 3 |
CAM
Carret Asset Management
New York
|
+$33.2K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$23.1K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$20K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$258K |
| 2 |
Two Sigma Investments
New York
|
-$62K |
| 3 |
Jane Street
New York
|
-$33.9K |
| 4 |
RS
R Squared
Central,
Hong Kong
|
-$21.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$12.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
National Bank of Canada
Montreal,
Quebec, Canada
| $2 | – | – | – |
|
|
AA
27
Ancora Advisors
Cleveland,
Ohio
| $1 | – | – | – |
|
|
AF
28
Aviso Financial
Toronto,
Ontario, Canada
| $1 | – | – | – |
|
|
MWA
29
Medallion Wealth Advisors
Farmington,
Connecticut
| $1 | – | – | – |
|
|
AUB
30
Atlantic Union Bankshares
Glen Allen,
Virginia
| $1 | +$1 | +1 | New |
|
31
Citigroup
New York
| $1 | +$1 | +1 | New |
|
|
DS
32
DRW Securities
Chicago,
Illinois
| – | -$258K | -168,453 | Closed |
|
|
33
Two Sigma Investments
New York
| – | -$62K | -40,513 | Closed |
|
|
34
Jane Street
New York
| – | -$33.9K | -22,170 | Closed |
|
|
RS
35
R Squared
Central,
Hong Kong
| – | -$21.1K | -13,771 | Closed |
|
|
36
Bank of America
Charlotte,
North Carolina
| – | -$12.9K | -8,453 | Closed |
|
|
TRCT
37
Tower Research Capital (TRC)
New York
| – | -$5.42K | -3,546 | Closed |
|
|
CWP
38
Concord Wealth Partners
Abingdon,
Virginia
| – | -$1.53K | -1,000 | Closed |
|
|
FDCDDQ
39
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$12 | -8 | Closed |
|
40
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1 | -1 | -8% |
|
BNGO Hedge Fund Activity: Q1 2026 in Review
32 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2026, worth a combined $1.02M — down 25% from $1.35M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BNGO positions and 8 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $129K. The largest seller was DRW Securities, exiting entirely with an estimated $258K sold.
- 32 institutional investors held Bionano Genomics (BNGO) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $1.02M of Bionano Genomics stock for Q1 2026, down 25% quarter-over-quarter.
- 9 funds opened new Bionano Genomics positions in Q1 2026 and 8 closed out, a net change of +1 holder.
- The largest Bionano Genomics buyer in Q1 2026 was Geode Capital Management, an estimated $129K added.
- The largest Bionano Genomics seller in Q1 2026 was DRW Securities, an estimated $258K sold.
Based on aggregated 13F filings for Q1 2026.